Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis

OBJECTIVES: Patients with Rheumatoid Arthritis (RA) are increasingly achieving stable disease remission, yet the mechanisms that govern ongoing clinical disease and subsequent risk of future flare are not well understood. We sought to identify serum proteomic alterations that dictate clinically impo...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Neil, Liam J., Hu, Pingzhao, Liu, Qian, Islam, Md. Mohaiminul, Spicer, Victor, Rech, Juergen, Hueber, Axel, Anaparti, Vidyanand, Smolik, Irene, El-Gabalawy, Hani S., Schett, Georg, Wilkins, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636686/
https://www.ncbi.nlm.nih.gov/pubmed/34867950
http://dx.doi.org/10.3389/fimmu.2021.729681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636686/
https://www.ncbi.nlm.nih.gov/pubmed/34867950
http://dx.doi.org/10.3389/fimmu.2021.729681

Ejemplares similares